Status:
TERMINATED
Intravitreal Bevacizumab for Age-Related Macular Degeneration
Lead Sponsor:
Asociación para Evitar la Ceguera en México
Conditions:
Age Related Macular Degeneration
Eligibility:
All Genders
50-99 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine whether intravitreal injection of bevacizumab is effective in the treatment of neovascular age related macular degeneration
Detailed Description
The neovascular age related macular degeneration(AMD) is a important cause of legal blindness in adults older than 50 years. Currently the treatment is photodynamic therapy that offer stabilization an...
Eligibility Criteria
Inclusion
- age \>50 age related macular degeneration
Exclusion
- moderate to severe cataract glaucoma intraocular surgery diabetes mellitus non controlled hypertension coronary artery disease
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2006
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00347165
Start Date
September 1 2005
End Date
September 1 2006
Last Update
May 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Luis Sanchez Bulnes
Mexico City, Mexico City, Mexico, 04030